Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.06.30
2016年公司债券受托治理事务报告(2019年度)
2020.06.30
2019年公司债券2019年按期受托治理事务报告
2020.06.24
关于刊发H股招股说明书、H股刊行价钱区间及H股香港果真发售等事宜的通告
2020.06.24
关于刊发H股刊行更新聆讯后资料集的通告
2020.06.22
2019年年度权益分派实验通告
2020.06.18
公司债券2020年跟踪评级报告
2020.06.17
《公司章程》(H股刊行后适用)修订比照表
2020.06.17
第四届董事会第三十五次聚会决议通告
2020.06.16
关于刊发H股刊行聆讯后资料集的通告
2020.06.13
关于香港团结生意所有限公司审议公司刊行境外上市外资股的通告
第一页
上一页
29
30
31
32
33
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】